Today: 22 June 2026

Wave Life Sciences (WVE) Stock News Today (Dec. 18, 2025): Why Shares Are Sliding, New Analyst Targets, and the Next Catalysts After WVE-007 Obesity Data

Wave Life Sciences (WVE) Stock News Today (Dec. 18, 2025): Why Shares Are Sliding, New Analyst Targets, and the Next Catalysts After WVE-007 Obesity Data

Wave Life Sciences shares fell to the mid-$15 range on December 18, 2025, following a volatile period sparked by positive Phase 1 data for its obesity drug candidate WVE-007 and a large equity offering. No new announcements drove the move; trading reflected continued volatility after the early December clinical data and financing. Analysts remain bullish, but dilution and early-stage risk weigh on the stock.
18 December 2025
Crinetics Pharmaceuticals (CRNX) Stock Drops After CMO Departure Filing: Latest News, Analyst Forecasts, and What’s Next (Dec. 18, 2025)

Crinetics Pharmaceuticals (CRNX) Stock Drops After CMO Departure Filing: Latest News, Analyst Forecasts, and What’s Next (Dec. 18, 2025)

Crinetics Pharmaceuticals shares fell about 8% Thursday after a regulatory filing disclosed Chief Medical and Development Officer Dr. Dana Pizzuti will step down December 31. She will transition to a Strategic Regulatory and Development Advisor role in early 2026. The stock traded in the low-to-high $40s as investors reacted to the leadership change.
18 December 2025
·
Carvana Stock (CVNA) News and Forecast: S&P 500 Inclusion, Analyst Targets, and the 2026 Setup (Dec. 18, 2025)

Carvana Stock (CVNA) News and Forecast: S&P 500 Inclusion, Analyst Targets, and the 2026 Setup (Dec. 18, 2025)

Carvana shares rose 3.8% to around $463 Thursday after S&P Dow Jones Indices confirmed the company will join the S&P 500 before trading opens Dec. 22. The move comes as U.S. equities rallied on inflation data and as analysts debate Carvana’s valuation following a dramatic rebound. Index inclusion is expected to drive buying from passive funds.
18 December 2025
··
UnitedHealth Group Stock (UNH) News Today, Dec. 18, 2025: Policy Risk, Optum Rx Changes, and Wall Street Forecasts

UnitedHealth Group Stock (UNH) News Today, Dec. 18, 2025: Policy Risk, Optum Rx Changes, and Wall Street Forecasts

UnitedHealth Group shares traded around $326–$327 midday on Dec. 18, 2025, after a volatile year marked by a 32.6% price drop. A Reuters report highlighted possible sharp ACA premium hikes in 2026 and UnitedHealth’s warning that enrollment could fall by two-thirds if subsidies are not extended. Legislative uncertainty around ACA subsidies remains high.
18 December 2025
·
Amphenol Stock (NYSE: APH) News Today, Forecasts, and Analyst Views for Dec. 18, 2025

Amphenol Stock (NYSE: APH) News Today, Forecasts, and Analyst Views for Dec. 18, 2025

Amphenol shares traded near $129 on Dec. 18, 2025, after falling 2% the previous day, leaving the stock about 12% below its November high. Recent filings show the Czech National Bank raised its stake in Q3 while Dudley & Shanley cut holdings. Debate continues over whether Amphenol’s valuation remains justified amid AI and data-center optimism. Market cap stands near $156 billion.
18 December 2025
·
Birkenstock (BIRK) Stock Slides on FY2026 Outlook as Tariffs and FX Bite, Despite a FY2025 Beat

Birkenstock (BIRK) Stock Slides on FY2026 Outlook as Tariffs and FX Bite, Despite a FY2025 Beat

Birkenstock shares fell 8% to $42.58 on Dec. 18 after the company posted record fiscal 2025 revenue of €2.1 billion and strong profit growth but issued cautious 2026 guidance citing tariff and currency pressures. The stock swung between $39.73 and $46.75 in heavy trading as investors reacted to margin concerns despite robust recent results.
18 December 2025
··
Edgewise Therapeutics Stock (EWTX) Today: Why Shares Fell on Dec. 18, 2025, Plus Latest News, Analyst Forecasts, and Key Clinical Catalysts

Edgewise Therapeutics Stock (EWTX) Today: Why Shares Fell on Dec. 18, 2025, Plus Latest News, Analyst Forecasts, and Key Clinical Catalysts

Edgewise Therapeutics shares fell 8.8% to $20.35 on Thursday, with no new company news released that day. The stock traded between $20.33 and $22.81 on volume of about 1.25 million shares. EWTX remains 38% below its 52-week high and 92% above its 52-week low. The company’s recent updates include a December stock option grant and a November board appointment.
18 December 2025
··
Accenture Stock (ACN) Slides After Q1 FY2026 Earnings Beat: AI Bookings Hit $2.2B, Guidance Holds, and Wall Street Weighs In (Dec. 18, 2025)

Accenture Stock (ACN) Slides After Q1 FY2026 Earnings Beat: AI Bookings Hit $2.2B, Guidance Holds, and Wall Street Weighs In (Dec. 18, 2025)

Accenture shares fell about 1% Thursday, trading near $270.84, after the company’s Q1 FY2026 revenue and earnings beat estimates but its Q2 guidance midpoint of $17.68 billion came in just under analyst forecasts. Quarterly revenue reached $18.7 billion, with new bookings at $20.9 billion and adjusted EPS at $3.94, up 10% year over year.
18 December 2025
···
Salesforce (CRM) Stock News Today (Dec. 18, 2025): Agentforce in ChatGPT, Qualified Acquisition, and Fresh Analyst Price Targets

Salesforce (CRM) Stock News Today (Dec. 18, 2025): Agentforce in ChatGPT, Qualified Acquisition, and Fresh Analyst Price Targets

Salesforce launched its Agentforce Sales tool inside ChatGPT, allowing users to query and update Salesforce data through natural language. The company also agreed to acquire Qualified, expanding its AI-driven marketing capabilities. Shares closed at $257.52, down 0.2%. Analysts updated ratings, focusing on Agentforce adoption and future growth.
18 December 2025
·
ABM Industries (NYSE:ABM) Stock Slides on Dec. 18 After Q4 Earnings: WGNSTAR Deal, 2026 Outlook, Dividend Hike and Analyst Calls

ABM Industries (NYSE:ABM) Stock Slides on Dec. 18 After Q4 Earnings: WGNSTAR Deal, 2026 Outlook, Dividend Hike and Analyst Calls

ABM Industries shares fell 10.6% Thursday to $43.13 after reporting adjusted Q4 EPS of $0.88, missing consensus, though revenue rose 5.4% to $2.295 billion, beating estimates. The company cited a $0.26 per-share hit from self-insurance adjustments and announced a $275 million acquisition. UBS downgraded the stock, citing margin and leverage concerns.
18 December 2025
···
Pfizer Stock (NYSE: PFE) News Today: 2026 Guidance, Analyst Price Targets, Medicare Pricing Pressure, and Pipeline Catalysts (Dec. 18, 2025)

Pfizer Stock (NYSE: PFE) News Today: 2026 Guidance, Analyst Price Targets, Medicare Pricing Pressure, and Pipeline Catalysts (Dec. 18, 2025)

Pfizer shares traded near $25.04 at 18:26 UTC on Dec. 18, steady after a sharp selloff earlier in the week following new 2025 and 2026 guidance. The company now expects 2025 revenue of about $62 billion and 2026 revenue of $59.5–$62.5 billion. Reuters reports highlight policy and pricing pressures, while Pfizer and Astellas announced positive Phase 3 results for PADCEV + Keytruda in bladder cancer.
18 December 2025
Trump Executive Order Today (Dec. 18, 2025): Marijuana Rescheduling, CBD Expansion and the Other Orders Driving Headlines

Trump Executive Order Today (Dec. 18, 2025): Marijuana Rescheduling, CBD Expansion and the Other Orders Driving Headlines

President Donald Trump signed an executive order Thursday directing federal agencies to speed up the process of reclassifying marijuana from Schedule I to Schedule III. The order also calls for expanded medical research and signals a Medicare policy shift allowing some beneficiaries to use hemp-derived CBD products. The administration has not released the full text of the order.
18 December 2025
Texas Instruments Incorporated Stock (TXN) Today: New Sherman Fab Starts Production as Analysts Split on 2026 Outlook

Texas Instruments Incorporated Stock (TXN) Today: New Sherman Fab Starts Production as Analysts Split on 2026 Outlook

Texas Instruments began chip production at its new 300mm wafer fab in Sherman, Texas, on Dec. 18, 2025. TXN shares rose 1.77% to $177.58 after the announcement. Wall Street remains divided on the company’s outlook, citing both long-cycle recovery hopes and concerns over inventory and capital spending. The Sherman facility is part of TI’s push for greater manufacturing control and supply reliability.
18 December 2025
·
Inspire Medical Systems (INSP) Stock Plunges on Medicare Coding Reversal: Latest News, Analyst Forecasts, and What Investors Are Watching

Inspire Medical Systems (INSP) Stock Plunges on Medicare Coding Reversal: Latest News, Analyst Forecasts, and What Investors Are Watching

Inspire Medical Systems shares fell sharply on December 18, 2025, after two Medicare contractors, CGS and Noridian, pulled CPT code 64568 for hypoglossal nerve stimulation and redirected billing to CPT 64582. The move cast doubt on a key reimbursement upgrade that had driven recent stock gains, sending INSP down in the mid-to-high teens by early afternoon.
18 December 2025
Natural Gas Price Today at 2:00 PM ET, Dec. 18, 2025: NYMEX Slips Below $4 After EIA Storage Draw, Warm Forecasts and LNG Crosscurrents

Natural Gas Price Today at 2:00 PM ET, Dec. 18, 2025: NYMEX Slips Below $4 After EIA Storage Draw, Warm Forecasts and LNG Crosscurrents

U.S. natural gas futures slipped below $4.00/mmBtu Thursday afternoon, erasing a morning rally after the EIA reported a 167 Bcf storage withdrawal for the week ending Dec. 12. Prices ranged from $3.91 to $4.22/mmBtu during the day. Total working gas stood at 3,579 Bcf, 32 Bcf above the five-year average. Traders cited mixed signals from strong demand and ample storage.
18 December 2025
·
AI Stocks Today (Dec. 18, 2025): Micron Ignites the AI Chip Rally as OpenAI Funding Talk and Data-Center Financing Fears Keep Wall Street on Edge

AI Stocks Today (Dec. 18, 2025): Micron Ignites the AI Chip Rally as OpenAI Funding Talk and Data-Center Financing Fears Keep Wall Street on Edge

Micron shares jumped 13.5% to $255.95 by early afternoon Thursday after the company issued a strong profit outlook and highlighted high demand for AI memory chips. The Philadelphia SE Semiconductor Index rose about 3%. Nvidia, AMD, Microsoft, Alphabet, and Meta also posted gains. Softer U.S. inflation data further boosted sentiment, sending Treasury yields lower and supporting tech stocks.
18 December 2025
···········
XRP Price Today at 1:58 PM ET (18.12.2025): XRP Holds Near $1.84 as Ripple Expands Institutional Push and ETF Inflows Continue

XRP Price Today at 1:58 PM ET (18.12.2025): XRP Holds Near $1.84 as Ripple Expands Institutional Push and ETF Inflows Continue

XRP traded at $1.84 at 1:58 p.m. ET Thursday, near the day’s low of $1.83 after a volatile session. The token has struggled to break above $2.00 despite U.S. CPI data showing a 2.7% annual rise, which lifted broader risk sentiment. XRP’s market cap stood near $110 billion, with 24-hour volume in the mid-$3 billion range. Futures open interest dropped to $3.31 billion, signaling weaker momentum.
18 December 2025
·
Bitcoin Price Today at 1:56 (18.12.2025): BTC Holds Near $86K After Soft CPI Surprise, ETF Inflows, and Central Bank Crosswinds

Bitcoin Price Today at 1:56 (18.12.2025): BTC Holds Near $86K After Soft CPI Surprise, ETF Inflows, and Central Bank Crosswinds

Bitcoin traded near $86,000 at 1:56 p.m. ET Thursday after an early rally toward $90,000 faded, with prices ranging from $85,355 to $89,230, according to CoinDesk and MEXC. The move followed U.S. inflation data showing CPI rose 2.7% in November, below forecasts, fueling rate-cut bets. Traders remained cautious as uncertainty lingered over data quality and market direction.
18 December 2025
·
1 … 1,319 1,320 1,321 1,322 1,323 … 2,091

Stock Market Today

  • CSL Shares Gain Spotlight Amid Defensive Healthcare Rotation
    June 21, 2026, 11:49 PM EDT. CSL (ASX: CSL) has returned to focus as investors rotate into defensive healthcare amid market uncertainty. The biotech giant, operating globally and headquartered in Australia, benefits from sustained demand for plasma therapies, vaccines, and chronic disease treatments regardless of economic conditions. Its three main pillars-CSL Behring's plasma-derived therapies, CSL Seqirus's influenza vaccines, and CSL Vifor's kidney and iron deficiency treatments-offer resilience through specialized, essential medical products. CSL's extensive plasma collection network provides a competitive edge. This broad, diversified portfolio positions CSL as a solid defensive growth stock on the ASX.

Latest articles

Cognizant (NASDAQ: CTSH) Slides 10% as Nasdaq-100 Exit Nears

Cognizant (NASDAQ: CTSH) Slides 10% as Nasdaq-100 Exit Nears

22 June 2026
Cognizant shares plunged 10.49% to $43.70, erasing $2.4 billion in equity value—more than its $2 billion 2026 buyback target—after Accenture’s narrowed growth outlook, a Berenberg downgrade, and looming Nasdaq-100 removal, even as S&P 500 and Nasdaq rallied; investors now eye Q2 guidance as the next key test.
Pentagon Could Outpace Tech Giants on Small Nuclear Projects

Pentagon Could Outpace Tech Giants on Small Nuclear Projects

22 June 2026
Valar Atomics’ Ward 250 became the first DOE-authorized advanced reactor built outside a national lab to achieve criticality, signaling a shift as U.S. defense demand accelerates small nuclear deployment, with the Army allocating over $2 billion for microreactors—moving the sector from policy to production and raising near-term demand expectations.
Go toTop